Education
About Us
Working with TipRanks
Follow Us
VGK - ETF AI Analysis
Top Page
Vanguard FTSE Europe ETF (VGK)
Rating:62Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several key holdings, such as ASML Holding NV and Nestlé SA, have delivered strong year-to-date performance, supporting the ETF's overall returns.
Low Expense Ratio
The ETF has a very low expense ratio compared to industry averages, making it cost-effective for investors.
Broad Geographic Exposure
The fund is diversified across multiple European countries, reducing reliance on any single economy.
Negative Factors
Underperforming Holdings
Some top holdings, like SAP SE, have shown weak year-to-date performance, which could drag on the fund's overall returns.
Sector Concentration Risk
The ETF has significant exposure to financials and industrials, which could make it vulnerable if these sectors face challenges.
Limited U.S. Exposure
With only a small allocation to U.S. companies, the fund may miss out on growth opportunities in the world's largest economy.
VGK vs. SPDR S&P 500 ETF (SPY)
AUM28.21B
RegionEurope
Expense Ratio0.06%
Beta0.68
IssuerVanguard
Inception DateMar 04, 2005
Dividend Yield2.86%
Asset ClassEquity
Index TrackedFTSE Developed Europe All Cap
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume2,601,341
30 Day Avg. Volume2,875,046
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
90.94Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1183
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VGK Summary
The Vanguard FTSE Europe ETF (VGK) is an investment fund that focuses on European companies across various industries and sizes. It follows the FTSE Developed Europe All Cap Index, giving investors exposure to a wide range of businesses in countries like the UK, France, and Germany. Some of its top holdings include well-known companies like Nestlé and AstraZeneca. This ETF is a good choice for those looking to diversify their portfolio internationally and benefit from the growth potential of European markets. However, new investors should be aware that its performance can fluctuate with the overall European economy.
How much will it cost me?The Vanguard FTSE Europe ETF (VGK) has an expense ratio of 0.06%, meaning you’ll pay $0.60 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, which typically costs less than actively managed funds.
What would affect this ETF?VGK could benefit from economic recovery in Europe, increased demand for healthcare and technology innovations, and strong performance from top holdings like ASML and SAP. However, it may face challenges from rising interest rates, geopolitical tensions, or sector-specific risks in financials and energy, which are significant parts of its portfolio.
VGK Top 10 Holdings
The Vanguard FTSE Europe ETF (VGK) leans heavily into financials and industrials, with notable contributions from healthcare and consumer sectors. Roche Holding AG is a bright spot, rising steadily thanks to its strong pharmaceutical pipeline, while AstraZeneca adds momentum with robust earnings and strategic growth. HSBC is also pulling its weight, benefiting from favorable valuation and dividend yield. On the flip side, SAP and Siemens are lagging, with bearish momentum and mixed signals holding back performance. Overall, VGK offers a balanced play on Europe, but its sector tilt and reliance on a few key names could amplify volatility.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.89% | $1.03B | €358.72B | 39.25% | 76 Outperform | |
| SAP SE | 1.86% | $659.92M | €242.59B | -10.16% | 66 Neutral | |
| AstraZeneca | 1.72% | $610.26M | £213.94B | 27.90% | 78 Outperform | |
| HSBC Holdings | 1.69% | $600.80M | HK$1.92T | 46.27% | 79 Outperform | |
| Nestlé SA | 1.68% | $596.62M | CHF199.66B | 12.93% | 71 Outperform | |
| Novartis AG | 1.61% | $570.49M | CHF202.12B | 14.17% | 80 Outperform | |
| Roche Holding AG | 1.57% | $558.84M | CHF250.59B | 35.86% | 73 Outperform | |
| Shell (UK) | 1.53% | $544.16M | £159.60B | 9.10% | 74 Outperform | |
| Siemens | 1.45% | $513.59M | €178.02B | 20.07% | 74 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 1.25% | $444.95M | €316.25B | 3.83% | 78 Outperform |
VGK Technical Analysis
Positive
―
Price Trends
80.35
Positive
79.19
Positive
75.73
Positive
Market Momentum
0.13
Negative
57.02
Neutral
95.25
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VGK, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 80.31, equal to the 50-day MA of 80.35, and equal to the 200-day MA of 75.73, indicating a bullish trend. The MACD of 0.13 indicates Negative momentum. The RSI at 57.02 is Neutral, neither overbought nor oversold. The STOCH value of 95.25 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VGK.
VGK Peer Comparison
Comparison Results
Performance Comparison
VGK
Vanguard FTSE Europe ETF
81.49
16.52
25.43%
EZU
iShares MSCI Eurozone ETF
―
―
―
BBEU
JPMorgan BetaBuilders Europe ETF
―
―
―
IEUR
iShares Core MSCI Europe ETF
―
―
―
HEDJ
WisdomTree Europe Hedged Equity Fund
―
―
―
SPEU
SPDR Portfolio Europe ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents